Literature DB >> 3779650

Relation of in vitro properties to tumorigenicity for a series of sublines of the human breast cancer cell line MCF-7.

W B Butler, P J Berlinski, R M Hillman, W H Kelsey, M M Toenniges.   

Abstract

The relation of in vitro properties to tumorigenicity was studied using eight sublines of the human breast cancer cell line MCF-7. Four of the eight were tumorigenic in estrogen-treated nude mice. The sublines differed for each of the in vitro properties measured, and no property correlated perfectly with tumorigenicity. Cytochalasin B-induced multinucleation was a property of all four tumorigenic sublines but of only one of the four nontumorigenic ones. Anchorage-independent growth and concanavalin A-mediated hemadsorption levels were higher in all sublines than reported levels for nontransformed fibroblasts and normal human or mouse mammary epithelial cells. The production of both plasminogen activator and a plasminogen-independent fibrinolytic activity showed no relationship to tumorigenicity but was higher in those sublines producing more invasive tumors. It appears that no one of these in vitro properties is sufficient to make a subline tumorigenic. Rather, the first three properties studied here and, perhaps, also production of plasminogen activator may each be necessary, but not sufficient, to make a subline tumorigenic. In addition, properties such as production of plasminogen activator and other proteases, while perhaps not essential to tumorigenicity, may confer characteristics, such as invasiveness, on the tumors produced by a given subline.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3779650

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  22 in total

1.  Plasma levels of D-dimer: a crosslinked fibrin-degradation product in female breast cancer.

Authors:  C G Mitter; C C Zielinski
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

2.  CHIP buffers heterogeneous Bcl-2 expression levels to prevent augmentation of anticancer drug-resistant cell population.

Authors:  M Tsuchiya; Y Nakajima; T Waku; H Hiyoshi; T Morishita; R Furumai; Y Hayashi; H Kishimoto; K Kimura; J Yanagisawa
Journal:  Oncogene       Date:  2014-12-01       Impact factor: 9.867

3.  Subpopulations of MCF7 cells separated by Percoll gradient centrifugation: a model to analyze the heterogeneity of human breast cancer.

Authors:  M Resnicoff; E E Medrano; O L Podhajcer; A I Bravo; L Bover; J Mordoh
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

4.  Assessing the effect of a nude mouse model on nanoparticle-mediated gene delivery.

Authors:  Jamie L Betker; Thomas J Anchordoquy
Journal:  Drug Deliv Transl Res       Date:  2017-02       Impact factor: 4.617

5.  A 23-pS Ca2(+)-activated K+ channel in MCF-7 human breast carcinoma cells: an apparent correlation of channel incidence with the rate of cell proliferation.

Authors:  E A Wegman; J A Young; D I Cook
Journal:  Pflugers Arch       Date:  1991-02       Impact factor: 3.657

6.  Hydroxychloroquine inhibits autophagy to potentiate antiestrogen responsiveness in ER+ breast cancer.

Authors:  Katherine L Cook; Anni Wärri; David R Soto-Pantoja; Pamela Ag Clarke; M Idalia Cruz; Alan Zwart; Robert Clarke
Journal:  Clin Cancer Res       Date:  2014-06-15       Impact factor: 12.531

7.  Efficient inhibition of lung cancer in murine model by plasmid-encoding VEGF short hairpin RNA in combination with low-dose DDP.

Authors:  Yong P Ma; Yang Yang; Shuang Zhang; Xiang Chen; Na Zhang; Wei Wang; Zhi X Cao; Yu Jiang; Xia Zhao; Yu Q Wei; Hong X Deng
Journal:  J Exp Clin Cancer Res       Date:  2010-05-25

8.  Inhibition of postconfluent focus production in cultures of MCF-7 human breast cancer cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Authors:  J F Gierthy; D W Lincoln
Journal:  Breast Cancer Res Treat       Date:  1988-10       Impact factor: 4.872

9.  Optimization of estrogen growth response in MCF-7 cells.

Authors:  T E Wiese; L G Kral; K E Dennis; W B Butler; S C Brooks
Journal:  In Vitro Cell Dev Biol       Date:  1992 Sep-Oct

10.  GX15-070 (obatoclax) induces apoptosis and inhibits cathepsin D- and L-mediated autophagosomal lysis in antiestrogen-resistant breast cancer cells.

Authors:  Jessica L Schwartz-Roberts; Ayesha N Shajahan; Katherine L Cook; Anni Wärri; Mones Abu-Asab; Robert Clarke
Journal:  Mol Cancer Ther       Date:  2013-02-08       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.